Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  valganciclovir
Find trials that include:  Any drugs shown
Results 1-4 of 4 for your search:
Start Over
Efficacy and Safety of Maribavir in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment
Status: Active
Phase: Phase III
Type: Supportive care, Treatment
Age: 12 and over
Trial IDs: SHP620-303, NCI-2016-01720, 2015-004725-13, NCT02931539
Study for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
Status: Active
Phase: Phase III
Type: Supportive care, Treatment
Age: 16 and over
Trial IDs: SHP620-302, NCI-2017-00422, 2015-004726-34, NCT02927067
Tocilizumab with or without Zidovudine and Valganciclovir in Treating Patients with Kaposi Sarcoma Herpes Virus-Associated Multicentric Castleman Disease
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-C-0233, NCI-2013-01504, 110233, P10788, NCT01441063
Natural History of Zidovudine and Valganciclovir or Rituximab and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients with Kaposi Sarcoma-Associated Herpes Virus
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Treatment
Age: 18 and over
Trial IDs: 11-C-0220, NCI-2013-01499, P10760, 110220, NCT01419561
Start Over